Skip to main content
Top
Gepubliceerd in: Quality of Life Research 2/2021

18-12-2020 | Correction

Correction to: Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study

Auteurs: Janet H. Ford, Virginia L. Stauffer, Peter McAllister, Sreelatha Akkala, Matthew Sexson, David W. Ayer, Shufang Wang

Gepubliceerd in: Quality of Life Research | Uitgave 2/2021

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Excerpt

In the original publication, Fig. 3 showed an upward directed arrow for improvement in the monthly migraine headache days. However, the direction of the arrow has been corrected to downward direction, to present the improvement in monthly migraine headache days. …
Metagegevens
Titel
Correction to: Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study
Auteurs
Janet H. Ford
Virginia L. Stauffer
Peter McAllister
Sreelatha Akkala
Matthew Sexson
David W. Ayer
Shufang Wang
Publicatiedatum
18-12-2020
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 2/2021
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-020-02720-1

Andere artikelen Uitgave 2/2021

Quality of Life Research 2/2021 Naar de uitgave